Theragen Etex Co.,Ltd. (KOSDAQ:066700)
South Korea · Delayed Price · Currency is KRW 2,035.00
+73.00 (3.72%)
At close: Jul 31, 2026
Theragen Etex Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 74,651 | 115,919 | 99,857 | 143,064 | 141,464 | 205,154 | |
Market Cap Growth | -31.94% | 16.09% | -30.20% | 1.13% | -31.05% | -37.95% |
Enterprise Value | 97,835 | 141,838 | 141,473 | 162,967 | 168,496 | 248,833 |
Last Close Price | 2035.00 | 3160.00 | 3120.00 | 4470.00 | 4420.00 | 6410.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.84 | 10.94 | - | 5.46 | 14.80 | - |
Forward PE | - | 111.48 | 111.48 | 111.48 | 111.48 | 111.48 |
PS Ratio | 0.27 | 0.43 | 0.40 | 0.66 | 0.74 | 1.23 |
PB Ratio | 0.49 | 0.73 | 0.77 | 0.94 | 0.90 | 0.88 |
P/TBV Ratio | 0.59 | 0.87 | 0.93 | 1.07 | 1.00 | 0.93 |
P/FCF Ratio | 9.31 | 13.81 | - | 19.52 | 26.19 | 163.17 |
P/OCF Ratio | 6.95 | 10.57 | 55.85 | 11.80 | 14.75 | 51.20 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.36 | 0.52 | 0.57 | 0.75 | 0.88 | 1.49 |
EV/EBITDA Ratio | 6.98 | 8.50 | 7.97 | 9.41 | 9.94 | - |
EV/EBIT Ratio | 13.03 | 13.89 | 12.15 | 14.21 | 14.22 | - |
EV/FCF Ratio | 12.20 | 16.89 | - | 22.24 | 31.20 | 197.91 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.28 | 0.26 | 0.39 | 0.24 | 0.20 | 0.16 |
Debt / EBITDA Ratio | 2.99 | 2.50 | 2.84 | 2.10 | 1.84 | - |
Debt / FCF Ratio | 5.29 | 4.96 | - | 4.95 | 5.78 | 29.22 |
Net Debt / Equity Ratio | 0.02 | 0.02 | 0.20 | 0.09 | 0.06 | 0.10 |
Net Debt / EBITDA Ratio | 0.20 | 0.22 | 1.48 | 0.75 | 0.58 | -9.70 |
Net Debt / FCF Ratio | 0.36 | 0.43 | -2.74 | 1.78 | 1.82 | 18.41 |
Asset Turnover | 1.10 | 1.10 | 1.04 | 0.88 | 0.64 | 0.38 |
Inventory Turnover | 3.86 | 3.86 | 4.18 | 5.14 | 5.72 | 5.63 |
Quick Ratio | 1.17 | 1.18 | 0.88 | 1.03 | 1.09 | 0.92 |
Current Ratio | 1.57 | 1.58 | 1.28 | 1.35 | 1.43 | 1.22 |
Return on Equity (ROE) | 7.36% | 8.11% | -28.32% | 19.11% | 6.34% | -3.68% |
Return on Assets (ROA) | 1.93% | 2.58% | 3.03% | 2.93% | 2.48% | -1.05% |
Return on Invested Capital (ROIC) | 3.23% | 4.28% | 7.22% | 6.24% | 5.00% | -2.24% |
Return on Capital Employed (ROCE) | 4.70% | 6.10% | 8.50% | 7.30% | 6.90% | -2.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 13.03% | 9.14% | -41.04% | 18.32% | 6.76% | -5.78% |
FCF Yield | 10.74% | 7.24% | -9.62% | 5.12% | 3.82% | 0.61% |
Payout Ratio | 1.02% | 0.94% | - | - | - | - |
Buyback Yield / Dilution | -17.02% | -14.95% | 0.03% | - | -0.04% | -1.88% |